Overview

Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary Disease

Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if ramelteon has respiratory depressant effects in subjects with moderate to severe chronic obstructive pulmonary disease.
Phase:
Phase 4
Details
Lead Sponsor:
Takeda